O	O	O	0	8	Distinct	Distinct	B-NP	JJ	O	3	NMOD	O
O	O	O	9	18	signaling	signaling	I-NP	NN	O	3	NMOD	O
O	O	O	19	29	properties	property	I-NP	NNS	O	4	SUB	O
O	O	O	30	38	identify	identify	B-VP	VBP	O	0	ROOT	O
O	O	O	39	51	functionally	functionally	B-NP	RB	O	6	AMOD	O
O	O	O	52	61	different	different	I-NP	JJ	O	4	OBJ	O
T1	B-Protein	B-Protein	62	65	CD4	CD4	I-NP	NN	B-protein	8	NMOD	B-protein
T12	B-Entity	B-Entity	66	74	epitopes	epitope	I-NP	NNS	I-protein	6	NMOD	I-protein
O	O	O	74	75	.	.	O	.	O	4	P	O

O	O	O	77	80	The	The	B-NP	DT	O	3	NMOD	O
T2	B-Protein	B-Protein	81	84	CD4	CD4	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	85	95	coreceptor	coreceptor	I-NP	NN	I-protein	4	SUB	I-protein
O	O	O	96	105	interacts	interact	B-VP	VBZ	O	0	ROOT	O
O	O	O	106	110	with	with	B-PP	IN	O	4	VMOD	O
T13	B-Entity	B-Entity	111	114	non	non	B-NP	AFX	O	9	NMOD	O
T13	I-Entity	I-Entity	114	115	-	-	I-NP	HYPH	B-DNA	9	NMOD	B-DNA
T13	I-Entity	I-Entity	115	126	polymorphic	polymorphic	I-NP	JJ	I-DNA	9	NMOD	I-DNA
T13	I-Entity	I-Entity	127	134	regions	region	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	O	135	137	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	138	143	major	major	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	O	144	162	histocompatibility	histocompatibility	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	163	170	complex	complex	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	171	176	class	class	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	177	179	II	II	B-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	180	189	molecules	molecule	I-NP	NNS	I-protein	10	PMOD	I-protein
O	O	O	190	192	on	on	B-PP	IN	O	4	VMOD	O
O	O	O	193	200	antigen	antigen	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	O	200	201	-	-	O	HYPH	I-cell_type	18	P	I-cell_type
O	O	O	201	211	presenting	present	B-VP	VBG	I-cell_type	21	NMOD	I-cell_type
O	O	O	212	217	cells	cell	B-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	O	218	221	and	and	O	CC	O	4	VMOD	O
O	O	O	222	233	contributes	contribute	B-VP	VBZ	O	4	VMOD	O
O	O	O	234	236	to	to	B-PP	TO	O	23	VMOD	O
O	O	O	237	238	T	T	B-NP	NN	O	27	NMOD	O
O	O	O	239	243	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	O	244	254	activation	activation	I-NP	NN	O	24	PMOD	O
O	O	O	254	255	.	.	O	.	O	4	P	O

O	O	O	256	258	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	259	263	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	264	276	investigated	investigate	I-VP	VBN	O	2	VC	O
O	O	O	277	280	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	281	287	effect	effect	I-NP	NN	O	3	OBJ	O
O	O	O	288	290	of	of	B-PP	IN	O	5	NMOD	O
T3	B-Protein	B-Protein	291	294	CD4	CD4	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	295	305	triggering	triggering	I-NP	NN	O	6	PMOD	O
O	O	O	306	308	on	on	B-PP	IN	O	5	NMOD	O
O	O	O	309	310	T	T	B-NP	NN	O	13	NMOD	O
O	O	O	311	315	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	O	316	326	activating	activating	I-NP	NN	O	13	NMOD	O
O	O	O	327	334	signals	signal	I-NP	NNS	O	9	PMOD	O
O	O	O	335	337	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	338	339	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	340	348	lymphoma	lymphoma	I-NP	NN	O	17	NMOD	O
O	O	O	349	354	model	model	I-NP	NN	O	14	PMOD	O
O	O	O	355	360	using	use	B-VP	VBG	O	17	NMOD	O
O	O	O	361	371	monoclonal	monoclonal	B-NP	JJ	B-protein	20	NMOD	B-protein
O	O	O	372	382	antibodies	antibody	I-NP	NNS	I-protein	18	OBJ	I-protein
O	O	O	383	384	(	(	O	(	O	23	DEP	O
O	O	O	384	387	mAb	mAb	B-NP	NN	B-protein	23	DEP	B-protein
O	O	O	387	388	)	)	O	)	O	20	NMOD	O
O	O	O	389	394	which	which	B-NP	WDT	O	20	NMOD	O
O	O	O	395	404	recognize	recognize	B-VP	VBP	O	24	SBAR	O
O	O	O	405	414	different	different	B-NP	JJ	O	28	NMOD	O
T4	B-Protein	B-Protein	415	418	CD4	CD4	I-NP	NN	B-protein	28	NMOD	B-protein
T14	B-Entity	B-Entity	419	427	epitopes	epitope	I-NP	NNS	I-protein	25	OBJ	I-protein
O	O	O	427	428	.	.	O	.	O	2	P	O

O	O	O	429	431	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	432	443	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	444	448	that	that	B-SBAR	IN	O	2	VMOD	O
T5	B-Protein	B-Protein	449	452	CD4	CD4	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	453	463	triggering	triggering	I-NP	NN	O	6	SUB	O
O	O	O	464	472	delivers	deliver	B-VP	VBZ	O	3	SBAR	O
O	O	O	473	480	signals	signal	B-NP	NNS	O	6	OBJ	O
O	O	O	481	488	capable	capable	B-ADJP	JJ	O	7	NMOD	O
O	O	O	489	491	of	of	B-PP	IN	O	8	AMOD	O
O	O	O	492	502	activating	activate	B-VP	VBG	O	9	PMOD	O
O	O	O	503	506	the	the	B-NP	DT	O	16	NMOD	O
T15	B-Entity	B-Entity	507	509	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T15	I-Entity	I-Entity	509	510	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T15	I-Entity	I-Entity	510	512	AT	AT	I-NP	NN	I-protein	16	NMOD	I-protein
T15	I-Entity	I-Entity	513	526	transcription	transcription	I-NP	NN	O	16	NMOD	O
T15	I-Entity	I-Entity	527	533	factor	factor	I-NP	NN	O	10	OBJ	O
O	O	O	534	539	which	which	B-NP	WDT	O	16	NMOD	O
O	O	O	540	542	is	be	B-VP	VBZ	O	17	SBAR	O
O	O	O	543	551	required	require	I-VP	VBN	O	18	VC	O
O	O	O	552	555	for	for	B-PP	IN	O	19	VMOD	O
T6	B-Protein	B-Protein	556	567	interleukin	interleukin	B-NP	NN	B-protein	25	NMOD	B-protein
T6	I-Protein	I-Protein	567	568	-	-	B-NP	HYPH	O	25	NMOD	O
T6	I-Protein	I-Protein	568	569	2	2	I-NP	CD	O	25	NMOD	O
O	O	O	570	574	gene	gene	I-NP	NN	O	25	NMOD	O
O	O	O	575	585	expression	expression	I-NP	NN	O	20	PMOD	O
O	O	O	585	586	.	.	O	.	O	2	P	O

O	O	O	587	594	Whereas	Whereas	B-PP	IN	O	39	VMOD	O
O	O	O	595	604	different	different	B-NP	JJ	O	11	NMOD	O
O	O	O	605	609	anti	anti	I-NP	AFX	O	11	NMOD	O
O	O	O	609	610	-	-	I-NP	HYPH	O	11	NMOD	O
T7	B-Protein	B-Protein	610	613	CD4	CD4	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	614	617	mAb	mAb	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	618	620	or	or	I-NP	CC	O	11	NMOD	O
O	O	O	621	624	HIV	HIV	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	624	625	-	-	O	HYPH	I-protein	11	NMOD	I-protein
O	O	O	625	626	1	1	B-NP	CD	I-protein	11	NMOD	I-protein
T8	B-Protein	B-Protein	627	632	gp120	gp120	I-NP	NN	I-protein	12	SUB	I-protein
O	O	O	633	638	could	could	B-VP	MD	O	1	SBAR	O
O	O	O	639	642	all	all	O	DT	O	12	VMOD	O
O	O	O	643	650	trigger	trigger	B-VP	VB	O	12	VC	O
O	O	O	651	661	activation	activation	B-NP	NN	O	25	NMOD	O
O	O	O	662	664	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	665	668	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	669	676	protein	protein	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	677	685	tyrosine	tyrosine	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	686	693	kinases	kinase	I-NP	NNS	I-protein	16	PMOD	I-protein
T9	B-Protein	B-Protein	694	700	p56lck	p56lck	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	701	704	and	and	I-NP	CC	O	23	NMOD	O
T10	B-Protein	B-Protein	705	711	p59fyn	p59fyn	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	712	715	and	and	I-NP	CC	O	25	NMOD	O
O	O	O	716	731	phosphorylation	phosphorylation	I-NP	NN	O	14	OBJ	O
O	O	O	732	734	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	735	738	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	739	742	Shc	Shc	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	743	750	adaptor	adaptor	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	751	758	protein	protein	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	O	758	759	,	,	O	,	O	30	P	O
O	O	O	760	765	which	which	B-NP	WDT	O	30	NMOD	O
O	O	O	766	774	mediates	mediate	B-VP	VBZ	O	32	SBAR	O
O	O	O	775	782	signals	signal	B-NP	NNS	O	33	OBJ	O
O	O	O	783	785	to	to	B-PP	TO	O	34	NMOD	O
O	O	O	786	789	Ras	Ras	B-NP	NN	B-protein	35	PMOD	B-protein
O	O	O	789	790	,	,	O	,	O	39	P	O
O	O	O	791	795	they	they	B-NP	PRP	O	39	SUB	O
O	O	O	796	804	differed	differ	B-VP	VBD	O	0	ROOT	O
O	O	O	805	818	significantly	significantly	B-ADVP	RB	O	39	VMOD	O
O	O	O	819	821	in	in	B-PP	IN	O	39	VMOD	O
O	O	O	822	827	their	their	B-NP	PRP$	O	43	NMOD	O
O	O	O	828	835	ability	ability	I-NP	NN	O	41	PMOD	O
O	O	O	836	838	to	to	B-VP	TO	O	45	VMOD	O
O	O	O	839	847	activate	activate	I-VP	VB	O	43	NMOD	O
T16	B-Entity	B-Entity	848	850	NF	NF	B-NP	NN	B-protein	48	NMOD	B-protein
T16	I-Entity	I-Entity	850	851	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T16	I-Entity	I-Entity	851	853	AT	AT	I-NP	NN	I-protein	45	OBJ	I-protein
O	O	O	853	854	.	.	O	.	O	39	P	O

O	O	O	855	859	Lack	Lack	B-NP	NN	O	9	SUB	O
O	O	O	860	862	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	863	867	full	full	B-NP	JJ	O	4	NMOD	O
O	O	O	868	878	activation	activation	I-NP	NN	O	2	PMOD	O
O	O	O	879	881	of	of	B-PP	IN	O	4	NMOD	O
T17	B-Entity	B-Entity	882	884	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T17	I-Entity	I-Entity	884	885	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T17	I-Entity	I-Entity	885	887	AT	AT	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	888	893	could	could	B-VP	MD	O	0	ROOT	O
O	O	O	894	896	be	be	I-VP	VB	O	9	VC	O
O	O	O	897	907	correlated	correlate	I-VP	VBN	O	10	VC	O
O	O	O	908	910	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	911	912	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	913	925	dramatically	dramatically	I-NP	RB	O	15	AMOD	O
O	O	O	926	933	reduced	reduce	I-NP	VBN	O	16	NMOD	O
O	O	O	934	942	capacity	capacity	I-NP	NN	O	12	PMOD	O
O	O	O	943	945	to	to	B-VP	TO	O	18	VMOD	O
O	O	O	946	952	induce	induce	I-VP	VB	O	16	NMOD	O
O	O	O	953	960	calcium	calcium	B-NP	NN	O	20	NMOD	O
O	O	O	961	965	flux	flux	I-NP	NN	O	18	OBJ	O
O	O	O	966	969	and	and	O	CC	O	9	VMOD	O
O	O	O	970	975	could	could	B-VP	MD	O	9	VMOD	O
O	O	O	976	978	be	be	I-VP	VB	O	22	VC	O
O	O	O	979	991	complemented	complement	I-VP	VBN	O	23	VC	O
O	O	O	992	996	with	with	B-PP	IN	O	24	VMOD	O
O	O	O	997	998	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	999	1006	calcium	calcium	I-NP	NN	O	28	NMOD	O
O	O	O	1007	1016	ionophore	ionophore	I-NP	NN	O	25	PMOD	O
O	O	O	1016	1017	.	.	O	.	O	9	P	O

O	O	O	1018	1021	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1022	1029	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1030	1038	identify	identify	B-VP	VBP	O	0	ROOT	O
O	O	O	1039	1051	functionally	functionally	B-NP	RB	O	5	AMOD	O
O	O	O	1052	1060	distinct	distinct	I-NP	JJ	O	6	NMOD	O
T18	B-Entity	B-Entity	1061	1069	epitopes	epitope	I-NP	NNS	B-protein	3	OBJ	B-protein
O	O	O	1070	1072	on	on	B-PP	IN	O	6	NMOD	O
O	O	O	1073	1076	the	the	B-NP	DT	O	10	NMOD	O
T11	B-Protein	B-Protein	1077	1080	CD4	CD4	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1081	1091	coreceptor	coreceptor	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	1092	1100	involved	involve	B-VP	VBN	O	10	NMOD	O
O	O	O	1101	1103	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	1104	1114	activation	activation	B-NP	NN	O	23	NMOD	O
O	O	O	1115	1117	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1118	1121	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	1122	1125	Ras	Ras	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1125	1126	/	/	B-NP	SYM	O	20	NMOD	O
O	O	O	1126	1133	protein	protein	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1134	1140	kinase	kinase	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	1141	1142	C	C	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	1143	1146	and	and	O	CC	O	23	NMOD	O
O	O	O	1147	1154	calcium	calcium	B-NP	NN	O	23	NMOD	O
O	O	O	1155	1163	pathways	pathway	I-NP	NNS	O	12	PMOD	O
O	O	O	1163	1164	.	.	O	.	O	3	P	O
